# Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets and Boluses
> **Food and Drug Administration** · Final rule. · Published 2001-03-12 · Effective 2001-03-12 · 66 FR 14316
## Document
- **Document number:** 01-5681
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 66 FR 14316
- **CFR reference:** 21 CFR 520
- **Publication date:** 2001-03-12
- **Effective date:** 2001-03-12
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Phoenix Scientific, Inc. The supplemental NADA provides for oral use of a 200-milligram (mg) strength phenylbutazone tablet for relief of inflammatory conditions associated with the musculoskeletal system in dogs and horses.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2001/03/12/01-5681/oral-dosage-form-new-animal-drugs-phenylbutazone-tablets-and-boluses)
---
*AI Analytics · CC0 1.0*